Ontario’s recent decision to eliminate oxycontin and delist its replacement, oxyneo, from the Ontario Drug Benefit program sends a powerful message across the province; that something needs to be done about this epidemic addiction to prescription painkillers.Oxyneo is a tablet that is purposely difficult to crush and forms into a thick gel when added to liquid to prevent oxycodone from being extracted for use by injection.Basically, oxycontin will no longer be manufactured in Canada and it will be replaced with a new formulation called oxyneo by the end of February 2012. Additionally, the Ontario Drug Benefit program will not list oxyneo in their formulary; therefore no coverage will exist for those using this program to fund their habit. Dr. Irfan Dhalla of Toronto’s St. Michael’s Hospital